Global Next-Generation Sequencing Market in Healthcare Industry Analysis by Key Players, Projections, Innovation Overview and Forecast 2024

Summary
The” Next-Generation Sequencing Sequencing (NGS) Market” Report is a valuable source of knowledge for understanding world's main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast.

Description

Overview:
Next-generation sequencing (NGS) Market is the massively parallel sequencing technology that has revolutionized the biological sciences. With its ultra-high throughput, scalability, and speed, NGS enables researchers to perform a wide variety of applications and study biological systems at a level never before possible. Illumina, Pacific Biosciences of California, Thermo Fisher scientific and Oxford Nanopore technology offers next-generation sequencing Market instruments based on different technologies such as Reversible terminator sequencing, Sequencing by ligation, Single-molecule, real-time sequencing (SMRT), ion semiconductor sequencing technology and Nanopore sequencing technology respectively.

Wide range of diagnostic applications, continuous technology advancements are making it more efficient and user-friendly, but the complications associated with data storage and lack of skilled professional are some of the factors which may hamper growth to an extent.

Access This Next-Generation Sequencing (NGS) Market Report @ http://www.arcognizance.com/report/global-next-generation-sequencing-ngs-market-2018-2024

Key Players:
Illumina, Inc., Thermo Fisher Scientific, Inc., Pacific Biosciences of California, Oxford Nanopore Technologies Limited, Beijing Genomics Institute, Agilent Technologies, Inc., Qiagen N.V., Eurofins Scientific, F. Hoffmann-La Roche, DNASTAR, Inc., Biomatters Limited and other predominate and niche players.

Market Analysis:
The “Global Next-Generation Sequencing market” is estimated to witness a CAGR of 18.6% during the forecast period 2018–2024. The global market is analyzed based on five segments – Technology, Products, Application, End-users and regions.

Regional Analysis:
The regions covered in the report are the North America, Europe, Asia Pacific, and Rest of the World (ROW). North America is the major shareholder in the global next-generation sequencing market, followed by Europe. Asia-Pacific region is expected to grow at high CAGR during the forecasted period due to increasing funding for healthcare research, growing patient pool, and increasing healthcare expenditure. The markets in emerging counties such as, India, China and Brazil are expected to grow at a rapid pace for next five years.

Get Sample for Next-Generation Sequencing Market Report @ http://www.arcognizance.com/enquiry-sample/123448

Technology Analysis:
The next-generation sequencing market by technology is segmented into reversible terminator sequencing, ion semiconductor sequencing, sequencing by ligation, single molecule real-time sequencing, nanopore sequencing and others. Reversible terminator sequencing occupied a major market share in 2017 and is expected to remain same during the forecasted period.

Product Analysis:
The market by product type is segmented into instruments, consumables and reagents and services. The services segment of the NGS market includes data analysis services and sequencing services. Among various application, consumables and reagents occupied the largest share in 2017, due to increased usage and need of consumables throughout the sample preparation, library construction, and various other pre-requisite steps of next-generation sequencing Market.

Application Analysis:
The market by application is segmented into diagnostics, biomarker discovery, drug discovery, agriculture and animal research and others. Diagnostics includes prenatal testing, cancer diagnostics, genetic screening, pre-implantation, HLA typing and various other clinical diagnostics applications. The diagnostics application occupied a major share in 2017, due to increasing usage of next-generation sequencing Market for disease diagnosis.

End-Users Analysis:
The market by end-users is segmented into academic and research institutes, hospitals and clinics, biotech and pharma companies and others. Among various end-users of the NGS market, academic and research institutes occupied a major share in 2017.

Competitive Analysis:
Currently the next-generation sequencing market is consolidated with few key companies due to the involvement of complicated technologies and the requirement of high capital investment. Sequencing based test may soon be regarded as the gold standard in the field of molecular diagnostics. The increase in the applications of NGS has made many biotechnological firms and diagnostic laboratories to invest heavily in this field by launching new products or acquiring other smaller firms or by collaboration. For instance, in August 2017, US based Illumina and Telegraph Hill Partners launched Verogen, Inc. to drive adoption of NGS in the global forensic genomics Market. In February 2018, Twist Bioscience entered the NGS sample prep market with the launch of its first target enrichment products. In March 2017, MedGenome launched NGS based liquid biopsy blood test “Oncotrack” for the diagnosis of cancer in India.

Benefits:
The report provides complete details about the usage and adoption rate of Next-generation Sequencing Market in various therapeutic verticals and regions. With that, key stakeholders can know about the major trends, drivers, investments, and vertical player’s initiatives. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.

Key Stakeholders:

Companies Covered:
Illumina, Inc., Thermo Fisher Scientific, Inc., Pacific Biosciences of California, Oxford Nanopore Technologies Limited, Beijing Genomics Institute, Agilent Technologies, Inc., Qiagen N.V., Eurofins Scientific, F. Hoffmann-La Roche, DNASTAR, Inc., Biomatters Limited and other predominate and niche players

Buying This Next-Generation Sequencing Market Report @ http://www.arcognizance.com/discount/123448

Some Points Covered in Table of Contents:
1 Industry Outlook 8
1.1 Market Overview 8
1.2 Total addressable market 8

2 Report Outline 10
2.1 Report Scope 10
2.2 Report Summary 10
2.3 Research Methodology 11
2.4 Report Assumptions 12

3 Market Snapshot 13
3.1 Market Definition – Infoholic Research 13
3.2 Advantages of next-generation sequencing 13
3.3 Segmented Addressable Market (SAM) 13
3.4 Trends of the next-generation sequencing market 13
3.5 Related Markets 14
3.5.1 Polymerase chain reaction (PCR) 14
3.5.2 In-situ Hybridization 15
3.5.3 Microarray 15

4 Market Outlook 16
4.1 Market segmentation 16
4.2 PEST Analysis 16
4.3 Porter 5(Five) Forces 17

5 Market Characteristics 19
5.1 DRO – Global Next-generation sequencing Market Dynamics 19
5.1.1 Drivers 19
5.1.1.1 Usage of sequencing in wide range of diagnostic application 19
5.1.1.2 High speed, accuracy and reduced sequencing cost 20
5.1.2 Opportunities 21
5.1.2.1 Emerging applications of next-generation sequencing 21
5.1.2.2 Evolution of personalized medicine 21
5.1.3 Restraints 22
5.1.3.1 Complications associated with NGS data storage 22
5.1.3.2 Lack of skilled professional 22
5.2 DRO – Impact Analysis 23
5.3 Key Stakeholders 23

6 Technology: Market Size & Analysis 25
6.1 Overview 25
6.2 Reversible terminator sequencing 26
6.3 Ion semiconductor sequencing 27
6.4 Sequencing by ligation 27
6.5 Single molecule real-time (SMRT) sequencing 28
6.6 Nanopore sequencing 28
6.7 Others 29
…..

About Us:
http://arcognizance.com is an initiation in this new era of “analysis @ thought.” We are on a mission to replace the conventional research programs and give way to the latest methods and information for the organizations. We have created this hub of analytical research papers where you can get an access to the latest and the best research papers coming out from some reliable and budding research houses. After the advent of “new analytics" based on the data collection facilities of big data, the face of "business research facilities" has changed drastically . With ARC our experts have created a bookshelf where you can check out the research reports that are an outcome of the progression of knowledge in various industry sectors. Alongside you can also check some research papers, market reports, and forecasts that are talking about the "out of the box" developments in the market.

Contact Us:
Matt Wilson,
100 Church street, 8th floor,
Manhattan, New york, 10007
Phone No: +1 (646) 434-7969
Email: sales@arcognizance.com

This release was published on openPR.